148 related articles for article (PubMed ID: 10029581)
1. Autografting with philadelphia chromosome-negative mobilized hematopoietic progenitor cells in chronic myelogenous leukemia.
Carella AM; Lerma E; Corsetti MT; Dejana A; Basta P; Vassallo F; Abate M; Soracco M; Benvenuto F; Figari O; Podestá M; Piaggio G; Ferrara R; Sessarego M; Parodi C; Pizzuti M; Rubagotti A; Occhini D; Frassoni F
Blood; 1999 Mar; 93(5):1534-9. PubMed ID: 10029581
[TBL] [Abstract][Full Text] [Related]
2. High-dose chemo-radiotherapy followed by autologous Philadelphia chromosome-negative blood progenitor cell transplantation in patients with chronic myelogenous leukemia.
Carella AM; Chimirri F; Podestà M; Pitto A; Piaggio G; Dejana A; Lerma E; Pollicardo N; Vassallo F; Soracco M; Benvenuto F; Valbonesi M; Carlier P; Vimercati R; Prencipe E; Gatti AM; Ferrara RA; Incagliato M; Florio G; Frassoni F
Bone Marrow Transplant; 1996 Feb; 17(2):201-5. PubMed ID: 8640167
[TBL] [Abstract][Full Text] [Related]
3. Autografting with Ph-negative progenitors in patients at diagnosis of chronic myeloid leukemia induces a prolonged prevalence of Ph-negative hemopoiesis.
Podestà M; Piaggio G; Sessarego M; Pitto A; Figari O; Soracco M; Carella AM; Dejana A; Rosti V; Fugazza G; Ravera G; Lerma E; Cazzola M; Bacigalupo A; Frassoni F
Exp Hematol; 2000 Feb; 28(2):210-5. PubMed ID: 10706077
[TBL] [Abstract][Full Text] [Related]
4. Use of granulocyte-macrophage colony-stimulating factor (GM-CSF) in combination with hydroxyurea as post-transplant therapy in chronic myelogenous leukemia patients autografted with unmanipulated hematopoietic cells.
Carlo-Stella C; Regazzi E; Andrizzi C; Savoldo B; Garau D; Montefusco E; Vignetti M; Mandelli F; Rizzoli V; Meloni G
Haematologica; 1997; 82(3):291-6. PubMed ID: 9234574
[TBL] [Abstract][Full Text] [Related]
5. Autografting with cultured marrow in chronic myeloid leukemia: results of a pilot study.
Barnett MJ; Eaves CJ; Phillips GL; Gascoyne RD; Hogge DE; Horsman DE; Humphries RK; Klingemann HG; Lansdorp PM; Nantel SH
Blood; 1994 Aug; 84(3):724-32. PubMed ID: 8043861
[TBL] [Abstract][Full Text] [Related]
6. Intensive combination chemotherapy and autologous bone marrow transplantation leads to the reappearance of Philadelphia chromosome-negative cells in chronic myelogenous leukemia.
Kantarjian HM; Talpaz M; LeMaistre CF; Spinolo J; Spitzer G; Yau J; Dicke K; Jagannath S; Deisseroth AB
Cancer; 1991 Jun; 67(12):2959-65. PubMed ID: 1675151
[TBL] [Abstract][Full Text] [Related]
7. Quantitative competitive reverse transcriptase-polymerase chain reaction for BCR-ABL on Philadelphia-negative leukaphereses allows the selection of low-contaminated peripheral blood progenitor cells for autografting in chronic myelogenous leukemia.
Corsetti MT; Lerma E; Dejana A; Basta P; Ferrara R; Benvenuto F; Vassallo F; Abate M; Piaggio G; Parodi C; Sessarego M; Li Pira G; Manca F; Carella AM
Leukemia; 1999 Jul; 13(7):999-1008. PubMed ID: 10400414
[TBL] [Abstract][Full Text] [Related]
8. Comparative analysis of autografting in chronic myelogenous leukemia: effects of priming regimen and marrow or blood origin of stem cells.
Verfaillie CM; Bhatia R; Steinbuch M; DeFor T; Hirsch B; Miller JS; Weisdorf D; McGlave PB
Blood; 1998 Sep; 92(5):1820-31. PubMed ID: 9716614
[TBL] [Abstract][Full Text] [Related]
9. Cytogenetic response to autografting in chronic myelogenous leukemia correlates with the amount of BCR-ABL positive cells in the graft.
Corsetti MT; Lerma E; Dejana A; Cavaliere M; Figari O; Vassallo F; Abate M; Luchetti S; Piaggio G; Parodi C; Li Pira G; Manca F; Carella AM
Exp Hematol; 2000 Jan; 28(1):104-11. PubMed ID: 10658682
[TBL] [Abstract][Full Text] [Related]
10. Collection of Philadelphia-negative stem cells using recombinant human granulocyte colony-stimulating factor in chronic myeloid leukemia patients treated with alpha-interferon.
Hernández-Boluda JC; Carreras E; Cervantes F; Marín P; Arellano-Rodrigo E; Rovira M; Solé F; Lloveras E; Espinet B; Ocejo A; Montserrat E
Haematologica; 2002 Jan; 87(1):17-22. PubMed ID: 11801461
[TBL] [Abstract][Full Text] [Related]
11. Autografting in chronic myeloid leukemia.
Carella AM; Beltrami G; Corsetti MT
Semin Hematol; 2003 Jan; 40(1):72-8. PubMed ID: 12563613
[TBL] [Abstract][Full Text] [Related]
12. Percentage of Philadelphia chromosome (Ph)-negative and Ph-positive cells found after autologous transplantation for chronic myelogenous leukemia depends on percentage of diploid cells induced by conventional-dose chemotherapy before collection of autologous cells.
Talpaz M; Kantarjian H; Liang J; Calvert L; Hamer J; Tibbits P; Durett A; Claxton D; Giralt S; Khouri I
Blood; 1995 Jun; 85(11):3257-63. PubMed ID: 7756658
[TBL] [Abstract][Full Text] [Related]
13. Autologous transplantation for chronic myelogenous leukemia with mafosfamide-treated marrow.
Rizzoli V; Mangoni L; Almici C; Caramatti C; Dotti GP; Carlo-Stella C
Stem Cells; 1993 Oct; 11 Suppl 3():25-30. PubMed ID: 8298474
[TBL] [Abstract][Full Text] [Related]
14. High-dose hydroxyurea plus G-CSF mobilize BCR-ABL-negative progenitor cells (CFC, LTC-IC) into the blood of newly diagnosed CML patients at any time of hematopoietic regeneration.
Petzer AL; Hochenburger E; Haun M; Duba HCh; Grünewald K; Hoflehner E; Sill H; Linkesch W; Gastl G; Gunsilius E
J Hematother Stem Cell Res; 2002 Apr; 11(2):293-300. PubMed ID: 11983100
[TBL] [Abstract][Full Text] [Related]
15. Mobilization and transplantation of Philadelphia-negative peripheral-blood progenitor cells early in chronic myelogenous leukemia.
Carella AM; Cunningham I; Lerma E; Dejana A; Benvenuto F; Podestà M; Celesti L; Chimirri F; Abote M; Vassallo F; Figari O; Parodi C; Sessarego M; Valbonesi M; Carlier P; Prencipe E; Gatti AM; van den Berg D; Hoffman R; Frassoni F
J Clin Oncol; 1997 Apr; 15(4):1575-82. PubMed ID: 9193355
[TBL] [Abstract][Full Text] [Related]
16. Autologous transplant for chronic myelogenous leukemia using marrow treated ex vivo with mafosfamide.
Carlo-Stella C; Mangoni L; Almici C; Caramatti C; Cottafavi L; Dotti GP; Rizzoli V
Bone Marrow Transplant; 1994 Sep; 14(3):425-32. PubMed ID: 7994267
[TBL] [Abstract][Full Text] [Related]
17. Autografting Ph-negative blood precursor cells in chronic myeloid leukaemia.
Frassoni F; Giordano D; Podestà M; Piaggio G; Benvenuto F; Pitto A; Figari O; Dejana A; Lerma E; Vassallo F; Sessarego M; Carella A
Bone Marrow Transplant; 1996 May; 17 Suppl 3():S59-62. PubMed ID: 8769704
[TBL] [Abstract][Full Text] [Related]
18. Autografting in chronic myeloid leukemia with cultured marrow: update of the Vancouver Study.
Barnett MJ; Eaves CJ; Phillips GL; Hogge DE; Klingemann HG; Lansdorp PM; Nantel SH; Reece DE; Shepherd JD; Sutherland HJ
Stem Cells; 1993 Oct; 11 Suppl 3():64-6. PubMed ID: 7905324
[TBL] [Abstract][Full Text] [Related]
19. Autografting in chronic myelogenous leukemia: new questions.
Carella AM; Frassoni F; Negrin RS
Leukemia; 1995 Mar; 9(3):365-9. PubMed ID: 7885034
[TBL] [Abstract][Full Text] [Related]
20. Collection of Ph-negative progenitor cells from interferon responsive patients with chronic myeloid leukemia: effect of granulocyte-colony-stimulating factor mobilization.
Olavarria E; Parker S; Craddock C; Philpott N; Tiniakou M; Chase A; Kanfer E; Apperley JF; Goldman JM
Haematologica; 2000 Jun; 85(6):647-52. PubMed ID: 10870123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
